Charting the new era of
proteomics.
Erisyon Inc. is commercializing the world’s first single-molecule
protein sequencer that promises to transform the way we
detect, treat, and track disease.
Inheriting over a decade of work performed at the University of Texas at Austin’ s Center for Systems and Synthetic Biology, Erisyon was founded in March 2018 by a group of technologists and entrepreneurs with the ambition to usher in new discoveries that make the world healthier, safer, and more abundant.
Our Team
Talli Somekh
CEO
Jag Swaminathan PhD
CTO
Angela Bardo PhD
VP of Product
Prof Eric Anslyn
UT Austin
Prof Edward MArcotte
UT Austin